The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Advisers to the U.S. Food and Drug Administration will discuss recommendations for updated COVID-19 vaccines ahead of the ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...

UW Health's Dr. Jeff Pothof discusses new requirements from the U.S. Food and Drug Administration as it relates to yearly ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...